DAVITA INC.
DVAAPI behind this page
DVA Q3 2025 request
Playground key active
/api/financials?ticker=DVA&year=2025&quarter=3
Pick an endpoint and run the request.Income Statement
| Metric | Q3 2025 | Q3 2024 | YoY |
|---|---|---|---|
| Revenue From Contract With Customer Including Assessed Tax Net Of Provision For Uncollectible Accounts | 3,298,090 | 3,138,561 | +5.1% |
| Other Income | 122,137 | 125,029 | -2.3% |
Show Business Segments breakouts |
|||
| All Other Segments · Commercial Payors | 3,762 | 3,735 | +0.7% |
| All Other Segments · Medicare and Medicare Advantage | 85,877 | 104,217 | -17.6% |
| All Other Segments · Other | 28,994 | 13,496 | +114.8% |
| Other Operating Segments with Intersegment · Operating Segments | 115,862 | 118,825 | -2.5% |
| U S Dialysis And Related Lab Services with Intersegment · Operating Segments | 6,275 | 6,204 | +1.1% |
| U. S. Dialysis And Related Lab Services · Other | 6,275 | 6,204 | +1.1% |
Show Health Care Organization Revenue Sources breakouts |
|||
| Commercial Payors | 3,762 | 3,735 | +0.7% |
| Medicare and Medicare Advantage | 85,877 | 104,217 | -17.6% |
| Other | 35,269 | 19,700 | +79.0% |
| Revenue | 3,420,227 | 3,263,590 | +4.8% |
Show Business Segments breakouts |
|||
| All Other Segments | 452,119 | 373,730 | +21.0% |
| All Other Segments · Intersegment Elimination | -2,771 | -2,598 | -6.7% |
| Other Operating Segments with Intersegment · Operating Segments | 454,890 | 376,328 | +20.9% |
| U S Dialysis And Related Lab Services with Intersegment · Operating Segments | 2,980,040 | 2,906,000 | +2.5% |
| U. S. Dialysis And Related Lab Services | 2,968,108 | 2,889,860 | +2.7% |
| U. S. Dialysis And Related Lab Services · Intersegment Elimination | -11,932 | -16,140 | +26.1% |
Show Consolidation Items breakouts |
|||
| Intersegment Elimination | -14,703 | -18,738 | +21.5% |
| Operating Segments | 3,434,930 | 3,282,328 | +4.6% |
| Patient Care Costs | 2,332,759 | 2,151,875 | +8.4% |
Show Business Segments breakouts |
|||
| U. S. Dialysis And Related Lab Services · Operating Segments | 1,981,180 | 1,892,552 | +4.7% |
| General & Administrative | 414,373 | 393,534 | +5.3% |
Show Business Segments breakouts |
|||
| U. S. Dialysis And Related Lab Services · Operating Segments | 322,355 | 301,424 | +6.9% |
| Depreciation And Amortization | 177,490 | 187,014 | -5.1% |
Show Business Segments breakouts |
|||
| All Other Segments | 21,249 | 16,471 | +29.0% |
| U. S. Dialysis And Related Lab Services | 156,242 | 170,543 | -8.4% |
| Income Loss From Equity Method Investments | -10,162 | -3,711 | -173.8% |
| Total Costs & Expenses | 2,914,460 | 2,728,712 | +6.8% |
Show Business Segments breakouts |
|||
| All Other Segments · Operating Segments | 453,671 | 362,422 | +25.2% |
| U. S. Dialysis And Related Lab Services · Operating Segments | 2,449,927 | 2,356,524 | +4.0% |
| Operating Income | 505,767 | 534,878 | -5.4% |
Show Business Segments breakouts |
|||
| All Other Segments · Operating Segments | 1,219 | 13,906 | -91.2% |
| U. S. Dialysis And Related Lab Services · Operating Segments | 530,113 | 549,476 | -3.5% |
Show Consolidation Items breakouts |
|||
| Operating Segments | 531,332 | 563,382 | -5.7% |
| Interest And Debt Expense | -150,557 | -134,583 | -11.9% |
| Debt Prepayment Extinguishment And Modification Costs | -5,150 | -10,081 | +48.9% |
| Other Non-Operating Income (Expense) | -41,257 | -16,780 | -145.9% |
| Income Before Taxes | 308,803 | 373,434 | -17.3% |
| Income Tax Expense (Benefit) | 68,554 | 77,674 | -11.7% |
| Net Income | 240,249 | 295,760 | -18.8% |
| Net Income Loss Attributable To Noncontrolling Interest | -89,917 | -81,072 | -10.9% |
| Net Income | 150,332 | 214,688 | -30.0% |
| EPS (Basic) | 2.09 | 2.56 | -18.4% |
| EPS (Diluted) | 2.04 | 2.5 | -18.4% |
| Wtd Avg Shares (Basic) | 72,075 | 83,721 | -13.9% |
| Wtd Avg Shares (Diluted) | 73,769 | 85,795 | -14.0% |
| Comprehensive Income | 172,010 | 247,444 | -30.5% |
| Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax | -4,418 | -21,576 | +79.5% |
| Revenue From Contract With Customer Including Assessed Tax (Q) | — | — | — |
Show Business Segments breakouts |
|||
| All Other Segments · Commercial Payors | 98,630 | 58,648 | +68.2% |
| All Other Segments · Other Government Payors | 237,627 | 196,257 | +21.1% |
| Other Operating Segments with Intersegment · Operating Segments | 336,257 | 254,905 | +31.9% |
| Other Operating Segments with Intersegment · Operating Segments | 2,771 | 2,598 | +6.7% |
| U S Dialysis And Related Lab Services with Intersegment · Operating Segments | 2,973,765 | 2,899,796 | +2.6% |
| U S Dialysis And Related Lab Services with Intersegment · Operating Segments | 2,961,833 | 2,883,656 | +2.7% |
| U S Dialysis And Related Lab Services with Intersegment · Operating Segments | 11,932 | 16,140 | -26.1% |
| U. S. Dialysis And Related Lab Services · Commercial Payors | 956,887 | 954,807 | +0.2% |
| U. S. Dialysis And Related Lab Services · Medicaid and Managed Medicaid | 214,658 | 216,664 | -0.9% |
| U. S. Dialysis And Related Lab Services · Medicare and Medicare Advantage | 1,715,224 | 1,641,645 | +4.5% |
| U. S. Dialysis And Related Lab Services · Other Government Payors | 86,996 | 86,680 | +0.4% |
Show Health Care Organization Revenue Sources breakouts |
|||
| Commercial Payors | 1,055,517 | 1,013,455 | +4.2% |
| Medicaid and Managed Medicaid | 214,658 | 216,664 | -0.9% |
| Medicare and Medicare Advantage | 1,715,224 | 1,641,645 | +4.5% |
| Other Government Payors | 324,623 | 282,937 | +14.7% |
Balance Sheet
| Metric | Q3 2025 | Q3 2024 | YoY |
|---|---|---|---|
| Current Assets | |||
| Cash & Cash Equivalents | 705,960 | 1,070,775 | -34.1% |
| Marketable Securities (Current) | 30,524 | 20,996 | +45.4% |
| Accounts Receivable | 2,333,319 | 2,267,365 | +2.9% |
| Inventory | 139,092 | 128,999 | +7.8% |
| Other Receivables Net Current | 521,863 | — | — |
Show Accounts Notes Loans And Financing Receivable By Receivable Type breakouts |
|||
| IKC and Medicare | 302,177 | — | — |
| Prepaid Expenses & Other Current Assets | 160,968 | 96,989 | +66.0% |
| Total Current Assets | 4,111,826 | 4,037,000 | +1.9% |
| Non-Current Assets | |||
| Property, Plant & Equipment | 2,853,343 | 2,939,620 | -2.9% |
| Operating Lease Right-of-Use Assets | 2,323,123 | 2,418,350 | -3.9% |
| Marketable Securities (Non-Current) | 40,134 | 33,844 | +18.6% |
| Other Non-Current Assets | 204,479 | 218,956 | -6.6% |
| Goodwill | 7,543,878 | 7,227,630 | +4.4% |
Show Business Segments breakouts |
|||
| All Other Segments | 1,021,274 | 710,410 | +43.8% |
| U. S. Dialysis | 6,522,604 | — | — |
Show Business Acquisition breakouts |
|||
| Series Of Individually Immaterial Business Acquisitions | 68,763 | 139,606 | -50.7% |
| Total Assets | 17,555,892 | 17,503,737 | +0.3% |
Show Consolidated Entities breakouts |
|||
| Variable Interest Entity Primary Beneficiary | 565,428 | 294,071 | +92.3% |
| Other Assets | |||
| Restricted Cash And Cash Equivalents | 89,454 | 87,869 | +1.8% |
| Income Taxes Receivable | 130,646 | 4,522 | +2789.1% |
| Intangible Assets Net Excluding Goodwill | 219,673 | 197,854 | +11.0% |
| Investments In Affiliates Subsidiaries Associates And Joint Ventures | 259,436 | — | — |
| Current Liabilities | |||
| Accounts Payable | 655,598 | 488,244 | +34.3% |
| Other Liabilities Current | 933,985 | 927,530 | +0.7% |
| Employee Related Liabilities Current | 851,852 | 806,149 | +5.7% |
| Operating Lease Liability Current | 432,015 | 404,540 | +6.8% |
| Long Term Debt And Capital Lease Obligations Current | 62,921 | 296,255 | -78.8% |
| Accrued Income Taxes Current | 26,410 | 21,268 | +24.2% |
| Total Current Liabilities | 3,017,128 | 2,943,986 | +2.5% |
| Non-Current Liabilities | |||
| Operating Lease Liabilities | 2,099,531 | 2,237,135 | -6.2% |
| Other Non-Current Liabilities | 172,195 | 183,030 | -5.9% |
| Deferred Tax Liabilities | 742,453 | 659,581 | +12.6% |
| Total Liabilities | 16,215,170 | 15,284,063 | +6.1% |
Show Consolidated Entities breakouts |
|||
| Variable Interest Entity Primary Beneficiary | 236,449 | 125,404 | +88.5% |
| Other Liabilities | |||
| Due To Related Party | 54,347 | — | — |
Show Related Party Transaction breakouts |
|||
| Principal Owner | 54,347 | — | — |
| Long Term Debt And Capital Lease Obligations | 10,183,863 | 9,260,331 | +10.0% |
| Stockholders' Equity | |||
| Common Stock | 91 | 90 | +1.1% |
| Additional Paid In Capital Common Stock | 401,785 | 295,637 | +35.9% |
| Retained Earnings | 2,047,216 | 1,275,301 | +60.5% |
| Treasury Stock Value | -2,904,806 | -1,021,979 | -184.2% |
| Accumulated Other Comprehensive Income | -116,160 | — | — |
| Total Stockholders' Equity | -571,874 | 386,715 | -247.9% |
| Minority Interest | 267,642 | 199,948 | +33.9% |
| Stockholders Equity Including Portion Attributable To Noncontrolling Interest | -304,232 | 586,663 | -151.9% |
Show Equity Components breakouts |
|||
| Accumulated Other Comprehensive Income | -116,160 | -162,334 | +28.4% |
| Additional Paid In Capital | 401,785 | 295,637 | +35.9% |
| Common Stock | 91 | 90 | +1.1% |
| Noncontrolling Interest | 267,642 | 199,948 | +33.9% |
| Parent | -571,874 | 386,715 | -247.9% |
| Retained Earnings | 2,047,216 | 1,275,301 | +60.5% |
| Treasury Stock Common | -2,904,806 | -1,021,979 | -184.2% |
| Total Liabilities & Equity | 17,555,892 | 17,503,737 | +0.3% |
| Redeemable Noncontrolling Interest Equity Carrying Amount | 1,644,954 | 1,633,011 | +0.7% |
Cash Flow Statement
| Metric | YTD Q3 2025 | YTD Q3 2024 | YoY |
|---|---|---|---|
| Operating Activities | |||
| Depreciation Amortization And Accretion Net | 528,645 | 549,758 | -3.8% |
| Loss On Extinguishment Of Debt | 4,253 | 12,527 | -66.0% |
| Stock-Based Compensation | 101,559 | 75,392 | +34.7% |
| Deferred Income Taxes | 68,989 | -53,713 | +228.4% |
| Adjustment Income Loss From Equity Method Investments | 91,532 | 91,100 | +0.5% |
| Other Non-Cash Items | 11,522 | 24,159 | -52.3% |
| Change in Accounts Receivable | -144,688 | -175,643 | +17.6% |
| Change in Inventory | 913 | 20,495 | -95.5% |
| Increase Decrease In Other Current Receivables And Other Current Assets | -153,428 | 72,477 | -311.7% |
| Increase Decrease In Other Noncurrent Assets | -21 | -12,858 | +99.8% |
| Change in Accounts Payable | 97,879 | -43,414 | +325.5% |
| Increase Decrease In Employee Related Liabilities | 19,279 | 27,314 | -29.4% |
| Increase Decrease In Other Current Liabilities | 16,462 | 35,646 | -53.8% |
| Increase Decrease In Accrued Income Taxes Payable | -30,635 | -7,528 | -306.9% |
| Change in Other Liabilities | -14,172 | -7,646 | -85.4% |
| Net Cash from Operations | 1,345,774 | 1,474,411 | -8.7% |
| Investing Activities | |||
| Capital Expenditures | -430,434 | -384,786 | -11.9% |
| Payments To Acquire Businesses Gross | -118,337 | -161,210 | +26.6% |
Show Business Acquisition breakouts |
|||
| Series Of Individually Immaterial Business Acquisitions | -120,225 | -161,210 | +25.4% |
| Proceeds From Sales Of Business Affiliate And Productive Assets | 32,337 | 17,937 | +80.3% |
| Payments To Acquire Held To Maturity Securities | -15,842 | -15,319 | -3.4% |
| Payments To Acquire Other Investments | -3,352 | -8,784 | +61.8% |
| Proceeds From Sale And Maturity Of Held To Maturity Securities | 38,051 | 22,092 | +72.2% |
| Proceeds From Sale And Maturity Of Other Investments | 6,706 | 4,558 | +47.1% |
| Payments To Acquire Equity Method Investments | -2,466 | -4,497 | +45.2% |
| Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital | 1,514 | 6,554 | -76.9% |
| Net Cash from Investing | -491,823 | -523,455 | +6.0% |
| Financing Activities | |||
| Proceeds From Issuance Of Long Term Debt | 4,672,170 | 6,623,634 | -29.5% |
| Repayments Of Debt And Capital Lease Obligations | -3,880,721 | -5,437,907 | +28.6% |
| Payments Of Financing Costs | -26,416 | -46,011 | +42.6% |
| Purchase Of Treasury Stock From Related Party | -430,286 | — | — |
| Share Repurchases | -1,033,887 | -1,020,550 | -1.3% |
| Payments Of Distributions To Affiliates | -232,721 | -229,236 | -1.5% |
| Net Proceeds From Issuance Of Stock To Employees | 17,583 | 15,204 | +15.6% |
| Tax Withholding for Share Compensation | -33,764 | -127,700 | +73.6% |
| Proceeds From Contributions From Affiliates | 3,999 | 10,623 | -62.4% |
| Proceeds From Minority Shareholders | 169 | 860 | -80.3% |
| Payments To Minority Shareholders | -16,385 | -40,751 | +59.8% |
| Net Cash from Financing | -960,259 | -251,834 | -281.3% |
| Other Cash Flow | |||
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 21,897 | -5,112 | +528.3% |
| Net Change in Cash | -84,411 | 694,010 | -112.2% |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 795,414 | 1,158,644 | -31.3% |
Values in thousands USD. Source: SEC EDGAR 10-Q filing.